CHA Health

CHA Health Systems is a global healthcare enterprise specializing in biotechnology, regenerative medicine, and fertility treatments. Headquartered in South Korea with a significant presence in the United States and Australia, the company operates a comprehensive network of hospitals, research institutes, and biotech subsidiaries. Its core research focus is centered on stem cell and immune cell therapies, targeting conditions such as oncology, stroke, and degenerative disc disease. Through its subsidiary CHA Biotech, the group maintains a sophisticated R&D pipeline and clinical trial programs. Additionally, CHA Health is a world leader in reproductive medicine, having pioneered numerous advancements in In Vitro Fertilization (IVF) technology. The organization also provides CDMO services for cell and gene therapies through its subsidiary, Matica Biotechnology.